Open access · CC-BY
via OpenAlex
Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis
Iulia Szabo, Medeea O. Badii, Orsolya I. Gaal, Róbert Szabó, Claudia Sîrbe, Oana Humiță, Leo A. B. Joosten, Tania O. Crișan, Simona Rednic
International Journal of Molecular Sciences · 2023 · ▲ 6 citations
Abstract
High-throughput proteomic analysis could offer new insights into the pathogenesis of systemic sclerosis (SSc) and reveal non-invasive biomarkers for diagnosis and severity. This study aimed to assess the protein signature of patients with SSc compared to that of healthy volunteers, decipher various disease endotypes using circulating proteins, and determine the diagnostic performance of significantly expressed plasma analytes. We performed targeted proteomic profiling in a cohort of fifteen patients with SSc and eighteen controls using the Olink® (Olink Bioscience, Uppsala, Sweden)Target 96 Inflammation Panels. Seventeen upregulated proteins involved in angiogenesis, innate immunity, and co-stimulatory pathways discriminated between patients with SSc and healthy controls (HCs) and further classified them into two clusters, a low-inflammatory and a high-inflammatory endotype. Younger age, shorter disease duration, and lack of reflux esophagitis characterized patients in the low-inflammatory endotype. TNF, CXCL9, TNFRSF9, and CXCL10 positively correlated with disease progression, while the four-protein panel comprising TNF, CXCL9, CXCL10, and CX3CL1 showed high diagnostic performance. Collectively, this study identified a distinct inflammatory signature in patients with SSc that reflects a persistent T helper type 1 (Th 1) immune response irrespective of disease duration, while the multi-protein panel might improve early diagnosis in SSc.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms242417601
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Szabo, I., Badii, M.O., Gaal, O.I., Szabó, R., Sîrbe, C., Humiță, O., Joosten, L.A.B., Crișan, T.O., & Rednic, S. (2023). Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms242417601
Vancouver
Szabo I, Badii MO, Gaal OI, Szabó R, Sîrbe C, Humiță O, et al. Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417601.
BibTeX
@article{iulia2023Immune,
title = {Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis},
author = {Iulia Szabo and Medeea O. Badii and Orsolya I. Gaal and Róbert Szabó and Claudia Sîrbe and Oana Humiță and Leo A. B. Joosten and Tania O. Crișan and Simona Rednic},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417601},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Inflammatory Bowel Diseases 2014
Citation only
Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease
International Journal of Molecular Sciences 2026
Open access · CC-BY
Plasma Proteomics Reveals Persistent and Surgery-Responsive Molecular Signatures in Osteoarthritis Patients
Psychological Medicine 2019
Open access · CC-BY
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Frontiers in Immunology 2026
Open access · CC-BY
Integrated multi-omics profiling identifies aging-related molecular signatures and convergent interferon signaling in systemic lupus erythematosus
Frontiers in Immunology 2026
Open access · CC-BY
Large-scale plasma proteomics identifies proteins and pathways associated with incident interstitial lung disease
Nutrients 2024
Open access · CC-BY